The ability to source pharmaceutical products from the country of origin is always attractive to pharmaceutical wholesale buyers.
Sellers are always looking to expand their portfolio and get the best prices for their products. However, they are often limited by the number of buyers they have access to.
Products manufactured in Europe under EMA licenses are in demand across the globe. Clinical research companies and pharmaceutical importers outside Europe always seek direct sellers of European origin products at the best prices.
Our online platform helps sellers to post their availability, and buyers can submit offers in response. Sellers are also able to see lines in demand from buyers and make offers against them. Our digital solution reduces the time required for the procurement and also assists in improving the efficiency of the buying process.
With our platform, buyers can source the products at the best possible terms and get offers from sellers instantly. Medzexchange not only improves efficiency in communicating with the sellers but also assists in the buying process. FMD reports are verified as part of internal control procedures and GDP guidelines are strictly followed by the regulatory team.